GSK announced that the European Commission has approved Nucala (mepolizumab) as an add-on maintenance treatment for adults in the EU with uncontrolled COPD characterised by raised blood eosinophils ...

Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) today reported fourth-quarter and full-year 2025 results, announced 2026 ...

Revenue was $724.3 Million Net Loss from Continuing Operations Attributable to Shareholders was $46.2 Million or $0.16 Diluted Net Loss Per Share Adjusted Net Income ...